Price Surge Extends December Rally as DOJ Probe and “Going Concern” Risks Loom
December 23, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is back in the spotlight on Tuesday after another sharp move higher, extending a volatile December run that’s pulled in momentum traders—and raised fresh questions about fundamentals, governance, and legal risk.
As of late morning in U.S. trading, RGC was changing hands around the mid‑$23 range after opening higher, with the day’s trading range roughly $22.00–$23.99. [1]
Below is what’s driving the conversation around Regencell stock right now, based on the latest coverage and filings available on December 23, 2025.
RGC stock jumps again on Dec. 23 as it trades well above key averages
A widely-circulated market recap Tuesday noted that Regencell shares…
